The US Food and Drug Administration (FDA) has granted 510(k) clearance to the BioCharge Autobiologic Matrix, a bioresorbable ...

Straumann is in fine financial health. The firm has a healthy balance sheet and it has been averse to taking on any significant debt. It has held a debt/EBITDA below 1, on average, over the past 10 ...

Alongside its focus on execution and organic growth, the Group continued to make significant investments in production capacity, digital transformation, and the development of its workforce. Strong ...

Casting is open. Allergan Aesthetics is on the search for women to inspire women as one of the Faces of Natrelle. The ...

A mass of employees at the Food and Drug Administration (FDA) who were evaluating Elon Musk's brain implant venture, ...

Medications didn’t work, so this summer she sought help in a new FDA-cleared brain implant called Neuro One that can diagnose and treat epilepsy.

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Chicago-based The Aspen Group is seeing their consumer-focused investments pay off, and is ready to double down on those initiatives for continued growth this year. The Aspen Group supports several ...